Bupropion

( DrugBank: Bupropion / KEGG DRUG: Bupropion )


5 diseases
IDDisease name (Link within this page)Number of trials
8Huntington disease1
18Spinocerebellar degeneration1
21Mitochondrial disease1
IDDisease name (Link within this page)Number of trials
96Crohn disease1
171Wilson disease1

8. Huntington disease


Clinical trials : 242Drugs : 205 - (DrugBank : 62) / Drug target genes : 85 - Drug target pathways : 159 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

18. Spinocerebellar degeneration


Clinical trials : 76Drugs : 98 - (DrugBank : 31) / Drug target genes : 44 - Drug target pathways : 65 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

21. Mitochondrial disease


Clinical trials : 39Drugs : 42 - (DrugBank : 32) / Drug target genes : 47 - Drug target pathways : 67 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

96. Crohn disease


Clinical trials : 2,442Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

171. Wilson disease


Clinical trials : 79Drugs : 77 - (DrugBank : 17) / Drug target genes : 6 - Drug target pathways : 30 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries